FDA Advisory || December 24 and 31, 2021
In order to give the officials and employees sufficient time to prepare for the holiday season, work at the Food and Drug Administration (FDA) and its Field Offices is SUSPENDED […]
FDA Advisory No.2021-3381 || Resumption of FDA eServices System
Please be informed that the FDA eServices System is already up and running and shall now return to its usual operation. All stakeholders are hereby advised to submit their applications […]
FDA Advisory No.2021-3084 || Abridged Processing of Applications for Registration/ Notification of Medical Devices Approved by the Regulatory Authority of Any ASEAN Member Country
The Food and Drug Administration (FDA) supports the implementation of good regulatory reliance practices for increased efficiency of regulatory systems which will result to faster access to safe, quality and […]
FDA Advisory No.2021-2904 || Clarification on the Fees for the Five-Year Validity of CPR Application Pursuant to FDA Circular No. 2021-020
Pursuant to FDA Circular No. 2021-020 entitled “Revised Post-Marketing Surveillance Requirements for New Drugs under Monitored Release” dated 21 September, applicant for a Certificate of Product Registration (CPR) of New […]
FDA Advisory No.2021-2903 || Interim Application System in lieu of the Department of Information and Communication Technology (DICT) System Maintenance of License to Operate (LTO) for FDA eServices
This is in relation to the Department of Information and Communication Technology (DICT) Advisory dated 08 November 2021 on system maintenance entitled “Restoration of Government Common Platform (GCP) and New […]
FDA Advisory || Request for Insufficient Payment Posting (Initially Insufficient)
In line with Rule VII Section 2 (b) of the Implementing Rules and Regulations of Republic Act No. 11032, Otherwise Known as the “Ease of Doing Business and Efficient Government […]
FDA Advisory No.2021-2459 || Certification of Contraceptive Products in Compliance to the Implementing Rules and Regulations of the Republic Act No. 10354, Also Known as the Responsible Parenthood and Reproductive Health Act of 2012
In compliance with Republic Act No. 10354, also known as “The Responsible Parenthood and Reproductive Health Act of 2012” and its IRR, the Food and Drug Administration (FDA) hereby invites […]
FDA Advisory No.2021-2634 || Pilot Implementation of Food and Drug Administration eServices Portal System for License to Operate Application of Retailers of Medical Devices within the National Capital Region
The Food and Drug Administration (FDA) is currently developing the FDA eServices Portal System – an online platform for a streamlined License to Operate (LTO) application of FDA-regulated establishments. In […]
FDA Order No.2021-2059 || Temporary Ban of Entry of Pork Meat Products from New Identified Countries Implicated with African Swine Fever
In the interest of consistency and coherent efforts in preventing the entry of African Swine Fever Virus in the country, the Food and Drug Administration, following the Department of Agriculture […]
FDA Advisory No.2021-2341 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products:
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the following unregistered food products: 1. GREENFOREST SPICES & CONDIMENTS Laurel […]